DE60040019D1 - Gebundene ligande und deren verwendung - Google Patents

Gebundene ligande und deren verwendung

Info

Publication number
DE60040019D1
DE60040019D1 DE60040019T DE60040019T DE60040019D1 DE 60040019 D1 DE60040019 D1 DE 60040019D1 DE 60040019 T DE60040019 T DE 60040019T DE 60040019 T DE60040019 T DE 60040019T DE 60040019 D1 DE60040019 D1 DE 60040019D1
Authority
DE
Germany
Prior art keywords
domain
ligand
bonded ligands
receptor
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040019T
Other languages
English (en)
Inventor
Thomas J Schall
Brett Premack
Zhenhua Miao
Zheng Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemocentryx Inc
Original Assignee
Chemocentryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx Inc filed Critical Chemocentryx Inc
Application granted granted Critical
Publication of DE60040019D1 publication Critical patent/DE60040019D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
DE60040019T 1999-12-20 2000-12-18 Gebundene ligande und deren verwendung Expired - Lifetime DE60040019D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17297999P 1999-12-20 1999-12-20
US18662600P 2000-03-03 2000-03-03
US09/721,908 US6699677B1 (en) 1999-12-20 2000-11-24 Tethered ligands and methods of use
PCT/US2000/034503 WO2001046698A2 (en) 1999-12-20 2000-12-18 Tethered ligands and methods of use

Publications (1)

Publication Number Publication Date
DE60040019D1 true DE60040019D1 (de) 2008-10-02

Family

ID=27390216

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040019T Expired - Lifetime DE60040019D1 (de) 1999-12-20 2000-12-18 Gebundene ligande und deren verwendung

Country Status (9)

Country Link
US (1) US6699677B1 (de)
EP (1) EP1247103B1 (de)
JP (1) JP4777570B2 (de)
AT (1) ATE405838T1 (de)
AU (1) AU2440001A (de)
CA (1) CA2390690C (de)
DE (1) DE60040019D1 (de)
ES (1) ES2311485T3 (de)
WO (1) WO2001046698A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39849E1 (en) 1999-10-12 2007-09-18 Chemocentryx, Inc. Methods for identifying modulators of CCX CKR activity
US6998239B1 (en) * 1999-10-12 2006-02-14 Chemocentryx, Inc. Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
US6780602B2 (en) * 2001-11-01 2004-08-24 Microbiosystems, Limited Partnership Taxonomic identification of pathogenic microorganisms and their toxic proteins
US7413866B2 (en) * 2001-11-30 2008-08-19 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7504364B2 (en) 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
CA2487438A1 (en) * 2002-06-10 2003-12-18 Metabolex, Inc. Methods of treating and diagnosing diabetes with cx3cr1 modulators
US7469076B2 (en) 2003-09-03 2008-12-23 Receptors Llc Sensors employing combinatorial artificial receptors
US20040115634A1 (en) 2002-12-11 2004-06-17 Isis Pharmaceuticals, Inc. Modulation of stat 6 expression
US7981694B2 (en) * 2003-01-28 2011-07-19 The Regents Of The University Of California Solid phase isolation of proteins, nucleic acids and other macromolecules
GB0306428D0 (en) * 2003-03-20 2003-04-23 Oxagen Ltd Receptor proteins
EP1613737A4 (de) 2003-03-28 2008-12-03 Receptors Llc Reversibel immobilisierte bausteine beinhaltend künstliche rezeptoren und verfahren
WO2005013883A1 (en) * 2003-08-12 2005-02-17 Philips Intellectual Property & Standards Gmbh Closure device for a container
US20060094064A1 (en) * 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
JP2007513337A (ja) * 2003-11-19 2007-05-24 サトリス， インコーポレイテッド アルツハイマー病の診断方法、層化方法およびモニタリング方法
EP1789797A1 (de) 2004-09-03 2007-05-30 Receptors LLC Kombinatorische künstliche rezeptoren mit anbindungsbausteinen
EP1789792A2 (de) 2004-09-11 2007-05-30 Receptors LLC Kombinatorische künstliche rezeptoren mit peptidbausteinen
US7585968B2 (en) * 2005-03-28 2009-09-08 Isis Pharmaceuticals, Inc. Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
US20060258610A1 (en) * 2005-05-12 2006-11-16 Isis Pharmaceuticals, Inc. Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness
WO2007005715A2 (en) * 2005-07-01 2007-01-11 Inhibtex, Inc. Staphylococcal antibodies which cross-react with fungal antigens
EP2114999A2 (de) * 2006-12-12 2009-11-11 Biorexis Pharmaceutical Corporation Transferrin-fusionsproteinbibliotheken
US8846639B2 (en) * 2008-04-04 2014-09-30 Isis Pharmaceutical, Inc. Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
US20110202284A1 (en) * 2010-02-10 2011-08-18 Mcreynolds Cristopher Novel groups of biomarkers for diagnosing alzheimer's disease
US9163094B2 (en) 2011-09-27 2015-10-20 Massachusetts Institute Of Technology Light-activated fusion proteins and uses therefor
CN104884087B (zh) 2012-09-06 2019-07-30 阿德莱德研究创新有限公司 预防和/或治疗转移性癌症的产品和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6393994A (en) 1993-02-19 1994-09-14 Arris Pharmaceutical Corporation Thin film hpmp matrix systems and methods for constructing and displaying ligands
JPH07147987A (ja) 1993-05-28 1995-06-13 Wisconsin Alumni Res Found ユビキチン接合性酵素（ｅ２）融合タンパク質
US5763199A (en) 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
US5817527A (en) 1995-11-06 1998-10-06 Chiron Diagnostics Corporation Conjugation of ligand to immobilized protein in organic solvent
WO1997027299A1 (en) 1996-01-24 1997-07-31 Schering Corporation Mammalian cx3c chemokine genes
WO1998049557A1 (en) 1997-04-28 1998-11-05 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states

Also Published As

Publication number Publication date
AU2440001A (en) 2001-07-03
CA2390690C (en) 2010-08-10
US6699677B1 (en) 2004-03-02
WO2001046698A2 (en) 2001-06-28
EP1247103A2 (de) 2002-10-09
ATE405838T1 (de) 2008-09-15
EP1247103B1 (de) 2008-08-20
JP4777570B2 (ja) 2011-09-21
ES2311485T3 (es) 2009-02-16
CA2390690A1 (en) 2001-06-28
JP2003518138A (ja) 2003-06-03
WO2001046698A3 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
DE60040019D1 (de) Gebundene ligande und deren verwendung
Stern et al. Label-free electronic detection of the antigen-specific T-cell immune response
BR0313033A (pt) anticorpos, anticorpos monoclonais, linhagens de células de hibridoma, anticorpos receptores de anti-taci isolados, anticorpos anti -taci, métodos de modulação da atividade biológica
HK1082296A1 (en) Adhered membranes retaining porosity and biological activity in assay device for measuring serum cholesterol associated with high-density lipoproteins
US20060076249A1 (en) Measuring device and measuring method for detecting analytes
WO2001042786A3 (en) System for cell based screening : cell spreading
TW200514979A (en) Biosensor
ATE449963T1 (de) Immunoassays unter verwendung von sers (surface enhanced raman scattering)
DE69940198D1 (de) Mikrovorrichtung zum screening von biomolekülen
AU6834700A (en) Device and method for determining multiple analytes
GB2347223A (en) Method of electrochemical analysis of an analyte
AU2002365421A1 (en) Methods and compositions for detecting the activation state of the multiple proteins in single cells
ATE527543T1 (de) Testvorrichtung zur schnelldiagnose
WO2004057341A3 (en) Cvd assay
US7828949B2 (en) Biomolecule detection device, mobile phone for biomolecule detection, and biomolecule detection method
GB0618496D0 (en) Blood typing
Bennett et al. B‐cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle
ATE395363T1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
CA2366514A1 (en) Diagnostic and therapeutic use of antibodies against the urokinase receptor
NZ511217A (en) Method for measuring cellular adhesion
WO2001042503A3 (en) Apparatus and methods for drug screening based on nucleic acid analysis
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
WO2002071061A3 (en) Quantitative detection of the conformation changes of p-glycoprotein
DE69523492T2 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
DE3785175T2 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition